A 65-year-old man presented to our clinic for evaluation of a slowly enlarging nasal mass of 6 years' duration, with no nasal obstruction associated with the progression of the mass. He had experienced nasal trauma 8 years earlier. His medical history revealed that he had had gouty arthritis for approximately 20 years. His general practitioner had prescribed allopurinol for his gouty arthritis, but the patient's compliance had been poor.
the absence of local structure destruction, a benign lesion was suspected.
We performed an excisional biopsy. During the operation, a yellow-white mass, measuring 3 x 2.5 em, on the nasal dorsum with extension to the level of the upper lateral cartilages was noted . Final histopathology confirmed the diagnosis of a gouty tophus. Using polarized microscopy, an abundance of needle-shaped crystals was found ( figure 3 ).
Gout is a common inflammatory arthritis that results from monosodium urate crystal formation in or close to joints. The prevalence of gouty arthritis in Taiwan is 4.92%.1 Gouty tophi typically occur in the fingers, knees, wrists, subarticular regions of bone, bursae, and pressure points ,' however, nasal gouty tophus is extremely rare and can hardly be included in the differential diagnosis.
We describe this uncommon case of nasal gouty do .not intubate" status. In a meeting that included her designated healthcare proxy, she communicated her decision, expressed understanding of her condition, and appreciated the consequences of her choice. Given the absence of cognitive impairment or mood disorder, she was judged competent. The process of transfer to hospice care was initiated. However, the next evening the patient was found unresponsive in her hospital bed. Arterial blood gas showed hypercapnia and metabolic acidosis. After consultation with her healthcare proxy, she was placed on comfort measures only and expired the next morning.
In the oncogeriatric setting, the comprehensive geriatric assessment (CGA)l has been recognized as providing useful information supplementary to what can be obtained via standard oncology status assessments (e.g., the Eastern Cooperative Oncology Group Performance Status).' CGA is recommended before treatment decision making.'
The full CGA involves a team approach and thus can be time-consuming. There are, however, core components that should be evaluated early in the process to guide the remaining assessments and treatments. These include assessment of cognition, mood, social support, goals of care, and advance care preferences.
Determining patients' competence is critical in striking a proper balance between respecting the autonomy of those who can make informed decisions and protecting those with cognitive impairment.' The outcomes of such assessments not only have a significant impact on quality of end-of-life care and on the death and dying experience (Le., dying with dignity"), but they also have profound economic impact. Care for patients in their last year of life accounts for more than one-quarter of Medicare spending." tophus to help treating physicians gain awareness of this disease entity, especially for those physicians in the countries with a high prevalence of gouty arthritis. Surgical removal of gouty tophi is generally indicated when the lesions grow and cause symptoms or lead to cosmetic problems.
